Skip to main content
. 2013 Dec 20;35(2):282–326. doi: 10.1210/er.2013-1029

Table 12.

Therapeutic Agents for Hormonal Control

Hormonal Derangement Medication Dose per Day Side Effects
Hypercortisolism Mitotane 2–12 g, to target level 14–20 mg/L See Table 7, use mainly for adrenolytic effects
Mifepristone 300–1200 mg Fatigue, nausea, headache, hypokalemia, arthralgia, vomiting, edema, and endometrial thickening
Metyrapone 250–3000 mg Hyperandrogenemia
Ketoconazole 200–1200 mg Nausea, vomiting, abdominal pain, hepatotoxicity
Etomidate 0.02–0.03 mg/kg/h Sedation (usually occurs at significantly higher doses)
Aminoglutethemidea 250–1000 mg Rash, nausea, vomiting, anorexia, sedation, lethargy
Mineralocorticoid excess Spironolactone 25–200 mg Hyperkalemia, gynecomastia
Eplerenone 50–200 mg Hyperkalemia
Hyperandrogenemia Spironolactone Hyperkalemia, gynecomastia
Estrogen excess Aromatase inhibitors Anastrazole 1 mg Bone loss, nausea
Letrozole 2.5 mg
Exemestane 25 mg
SERMs (tamoxifen, raloxifene) Tamoxifen 20–40 mg, raloxifen 60 mg Deep venous thrombosis

Abbreviation: SERM, selective estrogen receptor modulator.

a

Not commonly available anymore.